Yi Hsu Huang
Director/Board Member bij ADVAGENE BIOPHARMA CO., LTD.
Profiel
Yi Hsu Huang was the founder of Mycenax Biotech, Inc. founded in 2001, where he held the title of Director from 2013 to 2019.
Currently, he is the Chief Executive Officer-Bioproduction Plant at National Health Research Institutes and a Director at Advagene Biopharma Co., Ltd.
since 2016.
He previously worked as the Chief Technology Officer & Deputy General Manager at Medigen Vaccine Biologics Corp.
Dr. Huang holds a doctorate degree from Auburn University and a graduate degree from Northwestern State University.
Actieve functies van Yi Hsu Huang
| Bedrijven | Functie | Begin |
|---|---|---|
| ADVAGENE BIOPHARMA CO., LTD. | Director/Board Member | 06-04-2016 |
| National Health Research Institutes | Corporate Officer/Principal | - |
Eerdere bekende functies van Yi Hsu Huang
| Bedrijven | Functie | Einde |
|---|---|---|
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Chief Tech/Sci/R&D Officer | 01-05-2021 |
| MYCENAX BIOTECH INC. | Founder | 15-08-2019 |
Opleiding van Yi Hsu Huang
| Auburn University | Doctorate Degree |
| Northwestern State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MYCENAX BIOTECH INC. | Health Technology |
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Health Technology |
| ADVAGENE BIOPHARMA CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| National Health Research Institutes |
